Validation study compares disease activity measures in a Chinese cohort, suggesting SLE-DAS is more accurate than SLEDAI-2-K.
SLE-DAS demonstrates superior accuracy in assessing disease activity compared to SLEDAI-2 K, likely attributable to refinements in assessing nephritis and hematological manifestations. Baseline SLE-DAS also exhibited a positive association with short-term organ damage accrual, though long-term validation is required.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: